USD 24.89
(-2.16%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 3.08 Billion USD | 7.38% |
2022 | 2.87 Billion USD | -13.99% |
2021 | 3.33 Billion USD | -9.51% |
2020 | 3.69 Billion USD | 80.26% |
2019 | 2.04 Billion USD | 39.73% |
2018 | 1.46 Billion USD | 1.03% |
2017 | 1.45 Billion USD | -12.12% |
2016 | 1.65 Billion USD | 11.49% |
2015 | 1.48 Billion USD | -13.09% |
2014 | 1.7 Billion USD | 337.79% |
2013 | 389 Million USD | -16.88% |
2012 | 468 Million USD | 45.34% |
2011 | 322 Million USD | -53.93% |
2010 | 699 Million USD | -39.85% |
2009 | 1.16 Billion USD | -21.11% |
2008 | 1.47 Billion USD | -0.34% |
2007 | 1.47 Billion USD | 1002.99% |
2006 | 134 Million USD | -69.41% |
2005 | 438 Million USD | 23.5% |
2004 | 354.64 Million USD | -3.59% |
2003 | 367.85 Million USD | -27.79% |
2002 | 509.39 Million USD | 24.93% |
2001 | 407.73 Million USD | 4.63% |
2000 | 389.68 Million USD | 208.04% |
1999 | 126.5 Million USD | -23.33% |
1998 | 164.99 Million USD | -3.75% |
1997 | 171.42 Million USD | -18.94% |
1996 | 211.49 Million USD | 12.47% |
1995 | 188.05 Million USD | -7.47% |
1994 | 203.24 Million USD | -52.9% |
1993 | 431.48 Million USD | 19.84% |
1992 | 360.06 Million USD | -34.73% |
1991 | 551.62 Million USD | -7.15% |
1990 | 594.11 Million USD | -2.33% |
1989 | 608.31 Million USD | 16.81% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 3.65 Billion USD | 0.0% |
2023 Q2 | 3.03 Billion USD | 0.0% |
2023 FY | 3.08 Billion USD | 7.38% |
2023 Q4 | 3.08 Billion USD | 0.0% |
2022 Q4 | 2.87 Billion USD | 0.0% |
2022 Q2 | 2.89 Billion USD | 0.0% |
2022 FY | 2.87 Billion USD | -13.99% |
2021 FY | 3.33 Billion USD | -9.51% |
2021 Q2 | 3.56 Billion USD | 0.0% |
2021 Q4 | 3.33 Billion USD | 0.0% |
2020 Q2 | 2.63 Billion USD | 0.0% |
2020 Q4 | 3.69 Billion USD | 0.0% |
2020 FY | 3.69 Billion USD | 80.26% |
2019 FY | 2.04 Billion USD | 39.73% |
2019 Q4 | 2.04 Billion USD | 0.0% |
2019 Q2 | 2.17 Billion USD | 0.0% |
2018 Q4 | 1.46 Billion USD | 0.0% |
2018 Q2 | 1.5 Billion USD | 0.0% |
2018 FY | 1.46 Billion USD | 1.03% |
2017 FY | 1.45 Billion USD | -12.12% |
2017 Q4 | 1.45 Billion USD | 0.0% |
2017 Q2 | 1.66 Billion USD | 0.0% |
2016 Q4 | 1.65 Billion USD | 0.0% |
2016 FY | 1.65 Billion USD | 11.49% |
2016 Q2 | 1.77 Billion USD | 0.0% |
2015 FY | 1.48 Billion USD | -13.09% |
2015 Q2 | 1.59 Billion USD | 0.0% |
2015 Q4 | 1.48 Billion USD | 0.0% |
2014 Q4 | 1.7 Billion USD | 0.0% |
2014 FY | 1.7 Billion USD | 337.79% |
2014 Q2 | 2.05 Billion USD | 0.0% |
2013 Q4 | 389 Million USD | 0.0% |
2013 Q2 | 383 Million USD | 0.0% |
2013 FY | 389 Million USD | -16.88% |
2012 Q4 | 468 Million USD | 578.26% |
2012 Q1 | 283 Million USD | -12.11% |
2012 FY | 468 Million USD | 45.34% |
2012 Q2 | 71 Million USD | -74.91% |
2012 Q3 | 69 Million USD | -2.82% |
2011 FY | 322 Million USD | -53.93% |
2011 Q4 | 322 Million USD | -35.6% |
2011 Q3 | 500 Million USD | -16.81% |
2011 Q2 | 601 Million USD | -1.15% |
2011 Q1 | 608 Million USD | -13.02% |
2010 Q1 | 1.05 Billion USD | -9.55% |
2010 Q2 | 1.08 Billion USD | 3.14% |
2010 FY | 699 Million USD | -39.85% |
2010 Q3 | 1.08 Billion USD | 0.46% |
2010 Q4 | 699 Million USD | -35.81% |
2009 FY | 1.16 Billion USD | -21.11% |
2009 Q4 | 1.16 Billion USD | -12.63% |
2009 Q2 | 1.39 Billion USD | 6.48% |
2009 Q3 | 1.33 Billion USD | -4.73% |
2009 Q1 | 1.31 Billion USD | -11.0% |
2008 Q3 | 1.54 Billion USD | -5.96% |
2008 FY | 1.47 Billion USD | -0.34% |
2008 Q1 | 1.62 Billion USD | 9.95% |
2008 Q2 | 1.64 Billion USD | 1.17% |
2008 Q4 | 1.47 Billion USD | -4.72% |
2007 Q1 | 144 Million USD | 7.46% |
2007 Q2 | 1.05 Billion USD | 631.94% |
2007 Q4 | 1.47 Billion USD | 20.26% |
2007 Q3 | 1.22 Billion USD | 16.6% |
2007 FY | 1.47 Billion USD | 1002.99% |
2006 Q4 | 134 Million USD | -12.42% |
2006 FY | 134 Million USD | -69.41% |
2006 Q1 | 152 Million USD | -42.42% |
2006 Q2 | 147 Million USD | -3.29% |
2006 Q3 | 153 Million USD | 4.08% |
2005 Q4 | 264 Million USD | -32.99% |
2005 Q3 | 394 Million USD | -44.64% |
2005 Q2 | 711.72 Million USD | 72.75% |
2005 Q1 | 412 Million USD | 21.96% |
2005 FY | 438 Million USD | 23.5% |
2004 Q1 | 418.91 Million USD | 13.88% |
2004 FY | 354.64 Million USD | -3.59% |
2004 Q4 | 337.81 Million USD | -18.72% |
2004 Q3 | 415.62 Million USD | -2.49% |
2004 Q2 | 426.25 Million USD | 1.75% |
2003 Q2 | - USD | -100.0% |
2003 Q1 | 563.18 Million USD | 10.56% |
2003 Q3 | - USD | 0.0% |
2003 FY | 367.85 Million USD | -27.79% |
2003 Q4 | 367.85 Million USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q4 | 509.39 Million USD | 0.0% |
2002 FY | 509.39 Million USD | 24.93% |
2001 FY | 407.73 Million USD | 4.63% |
2001 Q2 | - USD | 0.0% |
2001 Q4 | 407.73 Million USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q4 | 389.68 Million USD | 0.0% |
2000 FY | 389.68 Million USD | 208.04% |
1999 Q2 | - USD | 0.0% |
1999 Q4 | 126.5 Million USD | 0.0% |
1999 FY | 126.5 Million USD | -23.33% |
1998 FY | 164.99 Million USD | -3.75% |
1997 FY | 171.42 Million USD | -18.94% |
1996 FY | 211.49 Million USD | 12.47% |
1995 FY | 188.05 Million USD | -7.47% |
1994 FY | 203.24 Million USD | -52.9% |
1993 FY | 431.48 Million USD | 19.84% |
1992 FY | 360.06 Million USD | -34.73% |
1991 FY | 551.62 Million USD | -7.15% |
1990 FY | 594.11 Million USD | -2.33% |
1989 FY | 608.31 Million USD | 16.81% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 80.571% |
Allurion Technologies Inc. | 41.85 Million USD | -7267.943% |
Artivion, Inc. | 359.34 Million USD | -758.238% |
Avanos Medical, Inc. | 209.1 Million USD | -1374.892% |
Butterfly Network, Inc. | 25.02 Million USD | -12222.691% |
Butterfly Network, Inc. | 25.02 Million USD | -12222.691% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | -119.362% |
Boston Scientific Corporation | 9.49 Billion USD | 67.509% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | -211.121% |
Edwards Lifesciences Corporation | 694.9 Million USD | -343.805% |
Paragon 28, Inc. | 112.03 Million USD | -2652.834% |
Glaukos Corporation | 383.73 Million USD | -703.673% |
Globus Medical, Inc. | 520.4 Million USD | -492.617% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -12312.461% |
Integer Holdings Corporation | 1.04 Billion USD | -196.266% |
Medtronic plc | 26.04 Billion USD | 88.16% |
Nevro Corp. | 221.82 Million USD | -1290.273% |
Owlet, Inc. | 15.21 Million USD | -20168.139% |
Penumbra, Inc. | 234.34 Million USD | -1216.02% |
Vicarious Surgical Inc. | 14.83 Million USD | -20692.88% |
Sonendo, Inc. | 40.35 Million USD | -7542.933% |
STERIS plc | 3.38 Billion USD | 8.843% |
Stryker Corporation | 12.99 Billion USD | 76.268% |
Vapotherm, Inc. | 112.39 Million USD | -2643.968% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 48.559% |